We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Gamida Cell

News List

Clovis Oncology Appoints Ronit Simantov to its Board of Directors firstwordpharma
July 13, 2021
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today the appointment of Dr. Ronit Simantov to its Board of Directors, effective today.
Gamida Cell and Be The Match BioTherapies® Announce Strategic Collaboration pharmafocusasia
January 24, 2019
Gamida Cell Ltd., a leading cellular and immune therapeutics company, and Be The Match BioTherapies®, a subsidiary of the National Marrow Donor Program®/Be The Match® offering integrated platforms and ....
Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn americanpharmaceuticalreview
August 22, 2017
The first subject has been transplanted in an investigator-initiated study of Cordin for patients with severe aplastic anemia (AA) or hypoplastic myelodysplastic syndrome (MDS) who have no available matched donor. CordIn is produced by Gamida Cell.